How Data Analytics Improves Population Health Management

In response to the post by Toby Goldsmith MD, DLFAPA about changing lung cancer demographics and the dangers of delayed screening, I had to chime in. 🔗 And if you are looking to reduce healthcare unit costs by 70% and make the process smoother for patients? Here's how we can help streamline operations and boost efficiency: bit.ly/sly-home-li-general Check out the original post here: https://lnkd.in/gtJMiVu7 Here’s my video reply Would love to hear Rajni Bharara

🎀 Women’s cancers in the U.S. show progress — but deep disparities remain. A PLOS ONE (2025) study analyzing two decades of national data found that while breast cancer deaths are declining, uterine cancer incidence and mortality are rising, driven largely by obesity. Cervical cancer rates continue to fall overall, yet remain stagnant or worsening among American Indian and Alaska Native women. ⚕️ Black women still face the highest mortality rates for breast, cervical, and uterine cancers — despite similar or lower incidence — underscoring gaps in prevention, screening, and care access. 💡 Expanding HPV vaccination, obesity prevention, and equitable screening programs could drastically reduce these persistent racial and regional inequalities. 🧾 Published in PLOS ONE, 2025. Lead author: Ze Zhang. Source: https://lnkd.in/eKtbqtXR Published Date: October 13, 2025 👉 Comment BIOHACK if you want more science and health news like this! #BiohackYourself #HealthNews #ScienceNews #ResearchUpdates #Biohack Disclaimer: This content is for educational and entertainment purposes only and is not a substitute for medical advice. Always consult a healthcare professional. Full disclaimer: https://lnkd.in/eJE9Rsty 🧠 We explore all angles — ancient wisdom, modern science, and everything in between. No allegiance to Big Pharma or Big Natural. 🔍 We cite studies, but encourage you to read them, question funding, and review the methods. Stay curious. 📚 Not all journals are equal. Peer-reviewed ≠ perfect. Check the source, think critically, and decide for yourself. ⚠️ One study isn’t the full story. Science evolves. We’re here to inform, not to tell you what to believe.

🔬 Breast Cancer in 2025: More Diagnoses, Fewer Deaths. What This Means for Public Health. The latest data from the American Cancer Society (ACS) tell a complex story of progress and concern: 🩷 Death rates have dropped 44% since 1989, saving more than 518,000 lives through earlier detection, better screening, and advances in treatment. 📈 But new diagnoses are rising, increasing about 1% each year overall and 1.4% per year in women under 50 (2012–2021). As a public-health scientist focused on women’s health, I see this dual trend as both a success story and a warning sign. Why are cases rising? ▪️ Improved detection: we’re identifying cancers earlier and more accurately ▪️ Lifestyle shifts: higher body weight, lower activity, delayed childbearing ▪️ Environmental and social factors that increase exposure and risk Key Insights for 2025: ✅ Prevention gap: More women are developing disease despite better treatment. Primary prevention must stay at the center of policy. ✅ Equity imperative: Mortality declines are not equal. Younger (<40), older (>74), and certain racial/ethnic groups still face higher risks and lower access. ✅ Strategic opportunity: Use this progress to strengthen prevention, outreach, and screening equity — so survival gains are shared by all. Bottom line: Treatment saves lives. Prevention, early detection, and health equity will define the next decade of progress. Let’s keep asking: how can our health systems transform progress into prevention? Source: American Cancer Society, Breast Cancer Facts & Figures 2024–2025; CDC U.S. Cancer Statistics #PublicHealth #BreastCancerAwareness #HealthEquity #WomenInScience #CancerEpidemiology #WomenHealth #ScienceCommunication #PreventiveMedicine #EarlyDetection #PublicHealthLeadership

🌍 As the world ages, understanding the heterogeneity of disease prevalence among older adults is key to developing equitable healthcare strategies. 📊 Using data on 85 age-related diseases across regions, this study quantified disease diversity using the Shannon Diversity Index (SHDI) from 1990–2021. ⬆️ Higher SHDI (greater disease heterogeneity) in high-income countries like the U.S. and Sweden. ⬇️ Lower SHDI in South Asia and Oceania. 📉 Global SHDI decreased 1.2% since 1990 for both men and women, despite SHDI rising with age. ⚕️ Socio-economic factors, not climate, most strongly shaped global SHDI trends. 🩺 Addressing socio-economic and environmental inequalities is essential for reducing disparities in age-related diseases and promoting healthy aging worldwide. Key Points: Disease heterogeneity in aging populations shows significant geographic and temporal disparities High-income countries exhibit higher disease heterogeneity, while low-income regions concentrate on dominant diseases Disease heterogeneity in women showed greater sensitivity to environmental and socioeconomic factors than that in men DOI: https://lnkd.in/ezzaqQGj Chengcheng Jin, Jialian Chen, Jinqiong Fang, Kaiyu Hua, Zherui Fu, Xingxing Chen, Hao Wu, Ying Hua #GeoHealth #Aging #HealthInequality #PublicHealth #Epidemiology #HealthyAging

A Call to Action on Breast Cancer: Data, Disparity, and Prevention The latest data from the International Agency for Research on Cancer (IARC) presents a critical moment for global health. ➡️ The Projection: By 2050, we could see a 38% rise in global breast cancer incidence and a staggering 68% rise in deaths if current trends continue. ➡️The Disparity: This burden will disproportionately affect low-income countries, highlighting a urgent need for equitable healthcare solutions. But there is hope. An estimated 25% of breast cancers are preventable. The key lies in addressing modifiable risk factors like alcohol intake, physical inactivity, and maintaining a healthy weight. What can we do? 1. Promote Prevention: Empower communities and workforces with knowledge about protective factors, including breastfeeding. 2. Prioritize Early Detection: Advocate for and facilitate access to screenings and awareness programs, which are proven to save lives. At Memsha Consultancy & Training, we believe that a proactive approach to health is the cornerstone of a resilient society and a thriving workforce. We partner with organizations to build wellness strategies that make a tangible difference. Let's work together to change this trajectory. #BreastCancerAwareness#GlobalHealth #HealthEquity #Prevention #EarlyDetection #CorporateWellness #MemshaConsultancy #PublicHealth #IARC

There were so many fantastic presentations at this month’s Global Alliance for Genomics and Health Plenary. At 30:00 in the Day 2 conference livestream, you can hear Carolina Vitabäck's incredibly moving story about how data reuse drives improvements in the diagnosis and treatment of childhood cancers. https://lnkd.in/eEZZtFgu Sweden has an 85% survival rate for children with cancer. This isn’t because Swedish doctors are more competent or Swedes have better access to high-quality medications. Every resident in Sweden is enrolled in a national biobank at birth. Data from pregnant women and children can be linked, and multimodal health data and biomedical samples are reused to build individual and population health. Hearing Carolina’s incredibly moving story about how data reuse supported her child’s battle to survive cancer shines a light on how we can and must do better at enabling the reuse of multimodal biomedical data, and on what is possible when we can link and reuse data and samples across the lifespan. I wish everyone in the health policy space had the chance to hear such stories. Coupled with trustworthy data on the actual effects, costs, and cost savings of enabling multimodal data reuse, personal experiences like Carolina’s family's make an incredibly impactful case for addressing the challenge of siloed data and demonstrating how linked data provides life-saving opportunities for diagnosis and treatment in cancer and beyond.

🗓️ New Episode Release 🎙️ Global Health Dialogues – Dr. Kofi Mensah Nyarko on Women’s Cancers, Primary Care & Actionable Equity 🌍 🎧 Watch/Listen Now: https://lnkd.in/d5Zm4dXS How do we turn the tide on cancer in Africa—starting where care begins: the community clinic? In this episode, Princess Dina Mired sits down with Dr. Kofi Mensah Nyarko, Team Lead for NCDs & Mental Health at World Health Organization African Region, a physician–epidemiologist shaping continent-wide strategies to bring lifesaving cancer and NCD services closer to people—especially women. 🎙️ Their conversation explores: 🔗 Integrated care: screening and treatment for breast & cervical cancer embedded in primary health care 🏥 PEN & PEN+ models: practical pathways from prevention → early detection → treatment → palliation 💉 HPV vaccination and early detection to end late-stage diagnoses 👩🏾⚕️ Workforce innovation: task-sharing, training, and data-driven leadership 🤝 Partnerships with accountability (e.g., WICS) and the power of National Cancer Control Plans 📱 Digital health & AI to bridge distance and specialist gaps 🏛️ Domestic leadership & sustainable funding beyond pilots and short-term aid 🚭 Guarding against tobacco industry interference ✨ A clear, actionable roadmap for equitable cancer care—rooted in primary care, powered by partnerships, and led by governments. 💙 This episode is sponsored by Roche 🌍 Presented by OncoDaily Roche Africa #GlobalHealthDialogues #PrincessDinaMired #OncoDaily #WHOAFRO #WomensCancers #CancerCareInAfrica #PrimaryHealthCare #HPVVaccination #HealthEquity #GlobalHealth

Cancer in Asia-Pacific: A Crisis We Can Prevent A Lancet study warns that cancer deaths may rise by 75% globally by 2050, with the Asia-Pacific region accounting for over half of all new cases and deaths. In India alone, cancer rates have already jumped 26.4% since 1990 — among the highest worldwide. Behind these numbers lies a deeper truth: most cancers are detected too late. Yet, nearly 40% of cancer deaths are preventable through lifestyle changes and early screening. At Clinics on Cloud, we believe prevention begins with access. Our Health ATMs and digital health ecosystem are redefining primary care by making early cancer risk detection available where it matters most — in communities, workplaces, and rural health centers. 1. AI-driven cancer risk scoring based on vitals & lifestyle data 2. Early warning via symptom checkers & smart analytics 3. Affordable screening tie-ups (Pap smear, mammogram, oral & colon tests) 4. Awareness & education through digital kiosks and camps The future of oncology in APAC depends on how fast we shift from reactive treatment to proactive prevention. At Clinics on Cloud, we’re committed to building that future — one early detection at a time. #CancerAwareness #DigitalHealth #ClinicsOnCloud #PreventiveCare #HealthInnovation #Oncology #PublicHealth #CSR

A groundbreaking advancement in understanding health state values has emerged from the UK, utilizing the Functional Assessment of Cancer Therapy eight-Dimension utility instrument. This innovative study captures the perspectives of the UK general population, transforming subjective health experiences into vital quantitative data that can shape oncological treatment evaluations. Key findings reveal that pain and nausea carry the greatest impact on quality of life, highlighting the need for focused attention in treatment priorities. The research also affirms the importance of sociodemographic weighting to ensure results truly represent the broader population. By integrating multidimensional aspects of health-related quality of life into decision-making, this value set presents a robust framework for enhancing healthcare interventions and policies. This development marks a significant step forward in aligning public preferences with healthcare evaluations, fostering more patient-centered and effective approaches to cancer care. 🌟 Empowering data-driven decisions in oncology 💡 Elevating patient quality of life insights 📊 Bridging societal values with health outcomes #CancerCare #HealthEconomics #HealthPolicy #HealthcareInnovation #OncologyResearch #PatientCentric #Pharmacoeconomics #PublicHealth #Publications #QualityOfLife #RegulatoryAgencies #MarketAccess #MarketAccessToday

Personalized Prevention Through AI Introducing Heart Clusters As clinicians and health researchers, we know early prevention is key, yet risk prediction often remains too generic to guide meaningful change. Heart Clusters, developed by Nightingale, is an AI-powered tool that estimates an individual’s risk of heart disease based on: Demographics and anthropometrics Lifestyle patterns Pre-existing health conditions It then compares this profile to a large dataset cluster of similar individuals revealing where your patient stands within their peer group. The result? A more personalized, data-driven conversation about cardiovascular risk. 🔗 Try the interactive demo: Heart Clusters Let’s move from broad population risk to precision prevention. #DigitalHealth #Cardiology #AIinHealthcare #PreventiveMedicine #Nightingale